
Opinion|Videos|March 3, 2025
Key Takeaways on the Evolving Landscape of Pediatric Atopic Dermatitis Treatment
Panelists discuss the current treatment landscape for atopic dermatitis, noting significant advances in biologics and systemic therapies, and share optimism about the future of management, highlighting ongoing research and the potential for more targeted, personalized treatments to improve patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Please share final thoughts on the current treatment landscape and future of atopic dermatitis management.
Advertisement
Related to this article

In a Hirschsprung disease mouse model, diet shifted gut microbes and inflammation, with a 3-fold survival difference between standard diets.

The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.

ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.

Sleep specialist Rashi Kochhar, MD, explains how consistent bedtimes and wake times can support adequate sleep and daytime functioning during the school year.

A national claims analysis found 16.8% of pediatric GLP-1 users developed a nutritional deficiency within a year, most often vitamin D, while few received nutritional counseling.

Adding questions about routines and predictability may provide pediatricians with a broader picture of childhood adversity and mental health risk.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: What's new in IDSA's histoplasmosis treatment guidance?
2
GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
3
Predictability may be an overlooked factor in children's mental health
4
Fenfluramine shows sustained seizure reduction, functional improvement in Lennox-Gastaut syndrome
5

